AAPL350.78-2.00 (-0.57%) ▼|ABBV293.17-1.39 (-0.47%) ▼|ABT105.84-1.61 (-1.50%) ▼|ACN241.03-6.67 (-2.69%) ▼|ADBE237.25-8.75 (-3.56%) ▼|AMAT344.15-6.11 (-1.74%) ▼|AMD489.82-14.47 (-2.87%) ▼|AMGN459.74-2.58 (-0.56%) ▼|AMT189.23-1.51 (-0.79%) ▼|AMZN256.70-1.05 (-0.41%) ▼|AVGO338.53+5.13 (+1.54%) ▲|AXP315.62-3.43 (-1.08%) ▼|BA164.60-0.62 (-0.38%) ▼|BAC49.24-0.84 (-1.68%) ▼|BKNG154.89-2.64 (-1.68%) ▼|BLK1,185.20-12.77 (-1.07%) ▼|BMY60.92-2.01 (-3.19%) ▼|BNY149.90-1.79 (-1.18%) ▼|BRK-B591.48-1.38 (-0.23%) ▼|C119.40-1.92 (-1.58%) ▼|CAT566.19-4.30 (-0.75%) ▼|CL100.35-0.64 (-0.63%) ▼|CMCSA25.59-0.02 (-0.06%) ▼|COF187.81-5.41 (-2.80%) ▼|COP141.20+0.68 (+0.48%) ▲|COST1,114.66+0.92 (+0.08%) ▲|CRM197.02-17.81 (-8.29%) ▼|CSCO94.94+0.42 (+0.44%) ▲|CVS86.54-2.05 (-2.31%) ▼|CVX216.46-0.68 (-0.31%) ▼|DE650.88-3.11 (-0.48%) ▼|DHR227.20-2.71 (-1.18%) ▼|DIS118.68-0.02 (-0.02%) ▼|DUK130.54-0.05 (-0.04%) ▼|EMR160.23-0.42 (-0.26%) ▼|FDX321.08-6.57 (-2.01%) ▼|GD357.52-2.18 (-0.60%) ▼|GE325.54+0.36 (+0.11%) ▲|GEV768.58+5.01 (+0.66%) ▲|GILD171.02+3.44 (+2.05%) ▲|GM84.24+0.63 (+0.75%) ▲|GOOG279.14-2.12 (-0.75%) ▼|GOOGL281.98-1.74 (-0.61%) ▼|GS877.40-14.14 (-1.59%) ▼|HD339.93-7.58 (-2.18%) ▼|HON221.82+3.87 (+1.78%) ▲|IBM233.41-9.10 (-3.75%) ▼|INTC54.04-1.40 (-2.53%) ▼|INTU327.00-18.56 (-5.37%) ▼|ISRG432.60-5.15 (-1.18%) ▼|JNJ279.69-2.86 (-1.01%) ▼|JPM330.55-7.67 (-2.27%) ▼|KO99.24-0.25 (-0.25%) ▼|LIN522.47-0.99 (-0.19%) ▼|LLY1,415.99-15.68 (-1.10%) ▼|LMT590.15+4.94 (+0.84%) ▲|LOW223.15-1.79 (-0.79%) ▼|LRCX208.72-2.11 (-1.00%) ▼|MA649.67-12.04 (-1.82%) ▼|MCD277.11+2.44 (+0.89%) ▲|MDLZ67.49-0.06 (-0.08%) ▼|MDT103.14+0.26 (+0.25%) ▲|META622.83-3.58 (-0.57%) ▼|MMM181.87+0.19 (+0.10%) ▲|MO78.16-0.75 (-0.94%) ▼|MRK144.11-0.36 (-0.25%) ▼|MS183.37-2.21 (-1.19%) ▼|MSFT503.42-14.58 (-2.81%) ▼|MU701.73-17.30 (-2.41%) ▼|NEE85.07-0.27 (-0.32%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE37.32-0.95 (-2.47%) ▼|NOW93.10-6.27 (-6.31%) ▼|NVDA153.92-2.22 (-1.42%) ▼|ORCL114.48-4.61 (-3.87%) ▼|PEP143.64-2.79 (-1.91%) ▼|PFE28.51-0.36 (-1.23%) ▼|PG172.95-0.08 (-0.04%) ▼|PLTR156.81-3.58 (-2.23%) ▼|PM196.99+0.95 (+0.48%) ▲|QCOM167.13-1.39 (-0.82%) ▼|RTX197.32+2.43 (+1.25%) ▲|SBUX108.31-0.41 (-0.38%) ▼|SCHW91.20-1.75 (-1.88%) ▼|SO93.97-0.68 (-0.71%) ▼|SPG232.09-0.69 (-0.30%) ▼|T22.54+0.18 (+0.78%) ▲|TMO690.62-0.71 (-0.10%) ▼|TMUS170.21+0.20 (+0.12%) ▲|TSLA380.51+0.77 (+0.20%) ▲|TXN294.97+0.76 (+0.26%) ▲|UBER69.29-0.70 (-1.00%) ▼|UNH396.23-15.79 (-3.83%) ▼|UNP299.89-3.82 (-1.26%) ▼|UPS110.96-0.86 (-0.77%) ▼|USB59.45-0.98 (-1.62%) ▼|V419.49-6.97 (-1.63%) ▼|VZ46.33-0.01 (-0.02%) ▼|WFC82.89-1.95 (-2.30%) ▼|WMT127.83-0.58 (-0.45%) ▼|XOM167.44+0.57 (+0.34%) ▲|AAPL350.78-2.00 (-0.57%) ▼|ABBV293.17-1.39 (-0.47%) ▼|ABT105.84-1.61 (-1.50%) ▼|ACN241.03-6.67 (-2.69%) ▼|ADBE237.25-8.75 (-3.56%) ▼|AMAT344.15-6.11 (-1.74%) ▼|AMD489.82-14.47 (-2.87%) ▼|AMGN459.74-2.58 (-0.56%) ▼|AMT189.23-1.51 (-0.79%) ▼|AMZN256.70-1.05 (-0.41%) ▼|AVGO338.53+5.13 (+1.54%) ▲|AXP315.62-3.43 (-1.08%) ▼|BA164.60-0.62 (-0.38%) ▼|BAC49.24-0.84 (-1.68%) ▼|BKNG154.89-2.64 (-1.68%) ▼|BLK1,185.20-12.77 (-1.07%) ▼|BMY60.92-2.01 (-3.19%) ▼|BNY149.90-1.79 (-1.18%) ▼|BRK-B591.48-1.38 (-0.23%) ▼|C119.40-1.92 (-1.58%) ▼|CAT566.19-4.30 (-0.75%) ▼|CL100.35-0.64 (-0.63%) ▼|CMCSA25.59-0.02 (-0.06%) ▼|COF187.81-5.41 (-2.80%) ▼|COP141.20+0.68 (+0.48%) ▲|COST1,114.66+0.92 (+0.08%) ▲|CRM197.02-17.81 (-8.29%) ▼|CSCO94.94+0.42 (+0.44%) ▲|CVS86.54-2.05 (-2.31%) ▼|CVX216.46-0.68 (-0.31%) ▼|DE650.88-3.11 (-0.48%) ▼|DHR227.20-2.71 (-1.18%) ▼|DIS118.68-0.02 (-0.02%) ▼|DUK130.54-0.05 (-0.04%) ▼|EMR160.23-0.42 (-0.26%) ▼|FDX321.08-6.57 (-2.01%) ▼|GD357.52-2.18 (-0.60%) ▼|GE325.54+0.36 (+0.11%) ▲|GEV768.58+5.01 (+0.66%) ▲|GILD171.02+3.44 (+2.05%) ▲|GM84.24+0.63 (+0.75%) ▲|GOOG279.14-2.12 (-0.75%) ▼|GOOGL281.98-1.74 (-0.61%) ▼|GS877.40-14.14 (-1.59%) ▼|HD339.93-7.58 (-2.18%) ▼|HON221.82+3.87 (+1.78%) ▲|IBM233.41-9.10 (-3.75%) ▼|INTC54.04-1.40 (-2.53%) ▼|INTU327.00-18.56 (-5.37%) ▼|ISRG432.60-5.15 (-1.18%) ▼|JNJ279.69-2.86 (-1.01%) ▼|JPM330.55-7.67 (-2.27%) ▼|KO99.24-0.25 (-0.25%) ▼|LIN522.47-0.99 (-0.19%) ▼|LLY1,415.99-15.68 (-1.10%) ▼|LMT590.15+4.94 (+0.84%) ▲|LOW223.15-1.79 (-0.79%) ▼|LRCX208.72-2.11 (-1.00%) ▼|MA649.67-12.04 (-1.82%) ▼|MCD277.11+2.44 (+0.89%) ▲|MDLZ67.49-0.06 (-0.08%) ▼|MDT103.14+0.26 (+0.25%) ▲|META622.83-3.58 (-0.57%) ▼|MMM181.87+0.19 (+0.10%) ▲|MO78.16-0.75 (-0.94%) ▼|MRK144.11-0.36 (-0.25%) ▼|MS183.37-2.21 (-1.19%) ▼|MSFT503.42-14.58 (-2.81%) ▼|MU701.73-17.30 (-2.41%) ▼|NEE85.07-0.27 (-0.32%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE37.32-0.95 (-2.47%) ▼|NOW93.10-6.27 (-6.31%) ▼|NVDA153.92-2.22 (-1.42%) ▼|ORCL114.48-4.61 (-3.87%) ▼|PEP143.64-2.79 (-1.91%) ▼|PFE28.51-0.36 (-1.23%) ▼|PG172.95-0.08 (-0.04%) ▼|PLTR156.81-3.58 (-2.23%) ▼|PM196.99+0.95 (+0.48%) ▲|QCOM167.13-1.39 (-0.82%) ▼|RTX197.32+2.43 (+1.25%) ▲|SBUX108.31-0.41 (-0.38%) ▼|SCHW91.20-1.75 (-1.88%) ▼|SO93.97-0.68 (-0.71%) ▼|SPG232.09-0.69 (-0.30%) ▼|T22.54+0.18 (+0.78%) ▲|TMO690.62-0.71 (-0.10%) ▼|TMUS170.21+0.20 (+0.12%) ▲|TSLA380.51+0.77 (+0.20%) ▲|TXN294.97+0.76 (+0.26%) ▲|UBER69.29-0.70 (-1.00%) ▼|UNH396.23-15.79 (-3.83%) ▼|UNP299.89-3.82 (-1.26%) ▼|UPS110.96-0.86 (-0.77%) ▼|USB59.45-0.98 (-1.62%) ▼|V419.49-6.97 (-1.63%) ▼|VZ46.33-0.01 (-0.02%) ▼|WFC82.89-1.95 (-2.30%) ▼|WMT127.83-0.58 (-0.45%) ▼|XOM167.44+0.57 (+0.34%) ▲|
13.9 C
New York
Tuesday, November 17, 2026

Energy

University of Phoenix leaders present on artificial intelligence, academic policy, leadership development and workplace innovation at PACRAO 2026

Conference participation included presentations on emerging higher education topics and professional development initiativesPHOENIX, Nov. 17, 2026 /PRNewswire/ -- University of Phoenix leaders presented on artificial intelligence, academic policy management,...

My Green Condo Inc. Opens Patented Blockchain Accounting Framework (U.S. Patent No. 12,443,952) to SaaS Providers for M&A and Strategic Licensing

Building on its 2026 blockchain and tokenization roadmap, MGCOne invites legacy property management software...

Atain Appoints Jitendra Sindhwani (Jimpy) as Chief Executive Officer

WASHINGTON and GURGAON, India, Nov. 18, 2026 /PRNewswire/ -- Atain, an enterprise orchestration partner...

Summary in Progress: Anticipate Insights and Updates Soon

Palmetto Publishing, the author, presents a transformative journey of self-discovery and creativity, promising insights...

Approved Oil Secures Long-Term New York City Fuel Terminal Agreement with Sunoco, Ensuring Supply Capacity into The 2040s

NEW YORK, Oct. 26, 2026 /PRNewswire-HISPANIC PR WIRE/ -- Approved Oil has secured a long-term agreement with Sunoco for a new fuel terminal location...

Duke Energy Florida shares tips for warding off energy vampires, saving money

ST. PETERSBURG, Fla., Oct. 26, 2026 /PRNewswire/ -- This Halloween, Duke Energy Florida is reminding customers of the scary reality of energy "vampires" –...

Riboscience Presents Phase 1a/b Overall Survival Data for ENPP1 Inhibitor RBS2418 as Monotherapy and in Combination Therapy in Advanced Solid Tumors and Late-Line CRC

Median overall survival of 12 months with RBS2418 monotherapy in subjects with heavily pretreated tumors that express ENPP1 and cGAS proteins (TME-EG+ phenotype), versus...

Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment

Powered by whole-genome sequencing and MAESTRO* technology, the next-generation Oncodetect test takes a distinct approach to MRD, tracking up to 5,000 patient-specific variants with...

TransCode Therapeutics Presents Phase 1a Clinical Data for TTX-MC138 at ESMO Congress 2026

Poster highlights durable disease control, acceptable tolerability and exploratory evidence of treatment-associated antitumor immune activity in patients with advanced solid tumorsBOSTON, Oct. 26, 2026 /PRNewswire/...

WuXi AppTec Delivers Strong Q1-Q3 2026 Results and Further Raises Full-Year Guidance, Driven by Greater Success of Multiple Customers’ Products and CRDMO Model

SHANGHAI, Oct. 26, 2026 /PRNewswire/ -- WuXi AppTec (Stock Codes: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization),...

Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma

SAN FRANCISCO and SUZHOU, China, Oct. 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

Borr Drilling Limited – Prospector 5 Rig Incident Update

HAMILTON, Bermuda, Oct. 26, 2026 /PRNewswire/ -- Borr Drilling Limited (NYSE: BORR) (OSE: BORR) ("Borr Drilling") provides an update on the Prospector 5 incident offshore...

ESMO 2026 | Professors Jie Wang, Zhijie Wang and Jianchun Duan’s Team Reports 95.2% Disease Control With LK101 Combination Maintenance Therapy in Advanced NSCLC

BEIJING, Oct. 25, 2026 /PRNewswire/ -- On October 24, 2026, in Madrid, Spain, the team of Professors Jie Wang, Zhijie Wang and Jianchun Duan at...

Results of CARsgen’s Satri-cel for Adjuvant Treatment for Gastric Cancer Presented at ESMO Congress 2026

SHANGHAI, Oct. 25, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that...

Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity

- ASC39, an oral small molecule selective amylin receptor agonist, demonstrated eloralintide-like amylin selectivity and efficacy in preclinical models.- ASC39 demonstrated eloralintide-like selectivity for...

2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein

The data showcased are from three Phase 1b clinical studies of IBI363/TAK-928 in first-line NSCLC, first-line G/GEJA, and immunotherapy-resistant lung adenocarcinoma, further supporting its...

Tennessee Oncology Researchers Help Lead Global Trial of Next-Generation Lung Cancer Therapy

Research Conducted at Tennessee Oncology's Greco-Hainsworth Centers for Research Contributes to Study Showing Longer Overall Survival with Next-Generation KRAS G12C TherapyNASHVILLE, Tenn., Oct. 25, 2026...

Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer Presented...

HONG KONG, Oct. 25, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) today announced the presentation of results from the randomized, controlled, double-blind, multicenter, registrational Phase...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.